Antimicrobial Stewardship Program: Time to be Focused in Speciality Settings of Leprosy Institute and Related Health Care Setup


如何引用文章

全文:

详细

Leprosy, often known as Hansen's disease is a contagious chronic infectious disease caused by Mycobacterium leprae (M. leprae). Our methodology is easily repeatable in tertiary care settings with diagnostic accuracy resources and staff capable of building a stewardship team. Comprehensive antimicrobial policies and programmes are required to properly alleviate the initial issue.

作者简介

Pugazhenthan Thangaraju

Department of Pharmacology, All India Institute of Medical Sciences (AIIMS)

编辑信件的主要联系方式.
Email: info@benthamscience.net

Hemasri Velmurugan

Department of Pharmacology, All India Institute of Medical Sciences (AIIMS)

Email: info@benthamscience.net

Sajitha Venkatesan

Department of Microbiology, All India Institute of Medical Sciences (AIIMS),

Email: info@benthamscience.net

参考

  1. WHO Leprosy . 2021. Available From: https://www.who.int/health-topics/leprosy#tab=tab_1
  2. Thangaraju P, Velmurugan H, Yella SST, Venkatesan S. vigilance needed in treating leprosy patients in accordance with WHO’s AWaRe Adv Anti-Infect Drug Discov 2022; 17(2): 95-102. doi: 10.2174/2772434417666220720111849 PMID: 35864797
  3. National Health Portal 2021.Available From https://www.nhp.gov.in/disease/skin/leprosy
  4. Lockwood DNJ, Penna GO, Lambert S, Pai VV, Walker SL. Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial? Lepr Rev 2022; 93(2): 96-101. doi: 10.47276/lr.93.2.96
  5. WHO Guidelines for the diagnosis, treatment and prevention of leprosy 2019. Available from: https://apps.who.int/iris/bitstream/handle/10665/274127/9789290226383-eng.pdf(Accessed: April 8, 2022)
  6. Thangaraju P, Kumar BA, Velmurugan H, Venkatesan S, Yella SST. Leprosy reactions: Clinical Pharmacologist perspective with repurposed medications. Infect Disord Drug Targets 2023; 23(2)e070922208607 doi: 10.2174/1871526522666220907125114 PMID: 36082854
  7. World Health Organization Available From: https://www.who.int/news-room/fact-sheets/detail/leprosy#:~:text=Leprosy%20is%20a%20curable%20disease,12%20months%20for%20MB%20cases (Accessed on Feb 25, 2023).
  8. Thangaraju P, Velmurugan H, Neelambaran K, Venkatesan S. Time to be vigilant in contacts of leprosy for possible single-dose rifampicin. JAAD Case Rep 2022; 29: 100-1. doi: 10.1016/j.jdcr.2022.05.014 PMID: 36212896
  9. CLTRI 2021. Available from: https://cltri.gov.in/about/default.html
  10. RLTRI Aska, Orissa. 2021. Available From: https://main.mohfw.gov.in/sites/default/files/8951774737RTI%20Report%20of%20RLTRI%20ASKA%2C%20ORISSA_0.pdf
  11. RLTRI . Raipur, Chattisgarh. 2021. Available From: http://rltrird.cg.gov.in/
  12. Directorate General of Health Services 2021. Available from: https://dghs.gov.in/content/1418_1_CenterLeprosyeachingandResearchInstituteCent.aspx
  13. Rao PN, Suneetha S. Current situation of leprosy in India and its future implications. Indian Dermatol Online J 2018; 9(2): 83-9. doi: 10.4103/idoj.IDOJ_282_17 PMID: 29644191
  14. Antimicrobial Stewarship Program 2021. Available from: https://apps.who.int/iris/bitstream/handle/10665/329404/9789241515481-eng.pdf
  15. Pai VV. Second-line anti-leprosy drugs: Indian experience. Indian J Drugs Dermatol 2020; 6(1): 1-4. doi: 10.4103/ijdd.ijdd_66_19
  16. Lazo-Porras M, Prutsky GJ, Barrionuevo P, et al. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: A systematic review and meta-analysis. BMC Infect Dis 2020; 20(1): 62. doi: 10.1186/s12879-019-4665-0 PMID: 31959113
  17. National Commission for the Incorporation of Technologies in the Unified Health System - CONITEC Media Consultations Reports 2021. Available From: https://www.gov.br/conitec/pt-br/midias/consultas/relatorios/2021/20211223_pcdt_hanseniase.pdf/view
  18. Message for World Leprosy Day 2022. Available From: https://www.who.int/news/item/10-01-2022-message-for-world-leprosy-day-2022
  19. Prabhu BP, Kunoor A, Sudhir S, et al. Antituberculosis treatment stewardship in a private tertiary care hospital in South India. Public Health Action 2018; 8(3): 151. doi: 10.5588/pha.18.0013 PMID: 30271733

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bentham Science Publishers, 2024